AJP - Heart and Circulatory Physiology, Vol 266, Issue 2 468-H475, Copyright © 1994 by American Physiological Society

ARTICLES

Effects of beta-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure

J. M. Levett, C. C. Marinelli, D. D. Lund, B. J. Pardini, S. Nader, B. D. Scott, N. V. Augelli, R. E. Kerber and P. G. Schmid Jr
Veterans Affairs Medical Center, Iowa City, Iowa.

We investigated neurohumoral profiles and transmitter and neuroenzyme markers of cardiac autonomic innervation in control (unpaced) dogs and three groups of dogs with pacing-induced heart failure (paced, paced + beta-adrenergic blockade, and paced + cardiac denervation). Left ventricular ejection fraction decreased significantly and to a comparable extent in all paced groups. Pacing increased plasma norepinephrine (NE); increases in NE were not attenuated but instead tended to be exaggerated by treatment with propranolol or cardiac denervation. Atrial hypertrophy occurred in all paced groups compared with the control group. However, atrial and right ventricular hypertrophy were not as pronounced in the paced plus cardiac denervation group as in the paced and paced plus propranolol groups. Pacing also depleted neuropeptide Y and NE from all heart chambers; propranolol treatment did not modify these local tissue changes. Pacing caused selective depletion of neuroenzymes predominantly in the left ventricle; again, propranolol did little to modify these changes. In this study of paced animals with experimentally maintained cardiac dysfunction, failure to modify noradrenergic responses with intrapericardial cardiac denervation suggests that noncardiac sources contribute predominantly to high plasma NE. Failure to modify neurohumoral, neuropeptide, and neuroenzyme responses with beta-antagonist suggests this treatment has little practical direct influence on sympathetic vasomotor activity or neuronal function in heart failure.

This article has been cited by other articles:

				R. Ramchandra, S. G. Hood, A. M. D. Watson, and C. N. May Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R719 - R726. [Abstract] [Full Text] [PDF]

				A. C. Kleiber, H. Zheng, H. D. Schultz, J. D. Peuler, and K. P. Patel Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1863 - R1872. [Abstract] [Full Text] [PDF]

				I. H. Zucker, J. F. Hackley, K. G. Cornish, B. A. Hiser, N. R. Anderson, R. Kieval, E. D. Irwin, D. J. Serdar, J. D. Peuler, and M. A. Rossing Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure Hypertension, November 1, 2007; 50(5): 904 - 910. [Abstract] [Full Text] [PDF]

				Y.-H. Du and A. F. Chen A "love triangle" elicited by electrochemistry: complex interactions among cardiac sympathetic afferent, chemo-, and baroreflexes J Appl Physiol, January 1, 2007; 102(1): 9 - 10. [Full Text] [PDF]

				N. S. Dhalla, M. R. Dent, P. S. Tappia, R. Sethi, J. Barta, and R. K. Goyal Subcellular Remodeling as a Viable Target for the Treatment of Congestive Heart Failure Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 31 - 45. [Abstract] [PDF]

				G.-Q. Zhu, L. Gao, K. P. Patel, I. H. Zucker, and W. Wang ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure J Appl Physiol, November 1, 2004; 97(5): 1746 - 1754. [Abstract] [Full Text] [PDF]

				G.-Q. Zhu, L. Gao, Y. Li, K. P. Patel, I. H. Zucker, and W. Wang AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1828 - H1835. [Abstract] [Full Text] [PDF]

				H. Shigematsu, Y. Hirooka, K. Eshima, M. Shihara, T. Tagawa, and A. Takeshita Endogenous angiotensin II in the NTS contributes to sympathetic activation in rats with aortocaval shunt Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1665 - R1673. [Abstract] [Full Text] [PDF]

				H. Yonemochi, S. Yasunaga, Y. Teshima, N. Takahashi, M. Nakagawa, M. Ito, and T. Saikawa Rapid Electrical Stimulation of Contraction Reduces the Density of {beta}-Adrenergic Receptors and Responsiveness of Cultured Neonatal Rat Cardiomyocytes : Possible Involvement of Microtubule Disassembly Secondary to Mechanical Stress Circulation, June 6, 2000; 101(22): 2625 - 2630. [Abstract] [Full Text] [PDF]

				J.-L. Liu, H. Murakami, M. Sanderford, V. S. Bishop, and I. H. Zucker ANG II and baroreflex function in rabbits with CHF and lesions of the area postrema Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H342 - H350. [Abstract] [Full Text] [PDF]

				J.-L. Liu and I. H. Zucker Regulation of Sympathetic Nerve Activity in Heart Failure : A Role for Nitric Oxide and Angiotensin II Circ. Res., March 5, 1999; 84(4): 417 - 423. [Abstract] [Full Text] [PDF]

				R. Ma, I. H. Zucker, and W. Wang Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2664 - H2671. [Abstract] [Full Text] [PDF]

				A. Sanbe and S. Takeo Long-term Treatment With Angiotensin I–Converting Enzyme Inhibitors Attenuates the Loss of Cardiac ß-Adrenoceptor Responses in Rats With Chronic Heart Failure Circulation, November 1, 1995; 92(9): 2666 - 2675. [Abstract] [Full Text]